Skip to content
About Us
Company Profile
Our Team
Regulation and Quality
Our values
Products
Theranostics
isoPROtrace11
Lu177
Radiopharmacy
PET Products
SPECT Products
Cold Kits
Lu177 Treatments
Services
CMO
Partnership
Partnerships & Distribution
Radiopharmaceuticals Companys
News
IsoBlog
Contact us
Careers
Menu
About Us
Company Profile
Our Team
Regulation and Quality
Our values
Products
Theranostics
isoPROtrace11
Lu177
Radiopharmacy
PET Products
SPECT Products
Cold Kits
Lu177 Treatments
Services
CMO
Partnership
Partnerships & Distribution
Radiopharmaceuticals Companys
News
IsoBlog
Contact us
Careers
Linkedin
FAPI Articles
Isotopia's Home page
»
FAPI Articles
Scientific Publications
FAPI
Articles
177 Lu-FAPI-46 Therapy in a Patient With End-Stage Metastatic Pancreatic Adenocarcinoma.
Feasibility and Therapeutic Potential of 177 Lu–Fibroblast Activation Protein Inhibitor–46 for Patients With Relapsed or Refractory Cancers A Preliminary Study.
Physiological tracer distribution and benign lesion incidental uptake of Al 18 F-NOTA-FAPI-04 on PET-CT imaging.
Could Fibroblast Activation Protein (FAP)-Specific Radioligands be considered a pan-tumor agents.
Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [18F]F-FDG in Oncology- A Systematic Review.
Theranostic Approach in Breast Cancer A Treasured Tailor for Future Oncology.
Clinical Results of Fibroblast Activation Protein Specific PET and Implications for Radiotherapy Planning- Systematic Review.
Presentations
FAPI Introduction